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OBJECTIVES We sought to prospectively assess whether self-reported periodontal disease is associated with
subsequent risk of cardiovascular disease in a large population of male physicians.
BACKGROUND Periodontal disease, the result of a complex interplay of bacterial infection and chronic
inflammation, has been suggested to be a predictor of cardiovascular disease.
METHODS Physicians’ Health Study I was a randomized, double-blind, placebo-controlled trial of aspirin
and beta-carotene in 22,071 U.S. male physicians. A total of 22,037 physicians provided
self-reports of presence or absence of periodontal disease at study entry and were included in
this analysis.
RESULTS A total of 2,653 physicians reported a personal history of periodontal disease at baseline.
During an average of 12.3 years of follow-up, there were 797 nonfatal myocardial infarctions,
631 nonfatal strokes and 614 cardiovascular deaths. Thus, for each end point, the study had
.90% power to detect a clinically important increased risk of 50%. In Cox proportional
hazards regression analysis adjusted for age and treatment assignment, physicians who
reported periodontal disease at baseline had slightly elevated, but statistically nonsignificant,
relative risks (RR) of nonfatal myocardial infarction, (RR, 1.12; 95% confidence interval [CI],
0.92 to 1.36), nonfatal stroke (RR, 1.10; CI, 0.88 to 1.37) and cardiovascular death (RR, 1.20;
CI, 0.97 to 1.49). Relative risk for a combined end point of all important cardiovascular events
(first occurrence of nonfatal myocardial infarction, nonfatal stroke or cardiovascular death)
was 1.13 (CI, 0.99 to 1.28). After adjustment for other cardiovascular risk factors, RRs were
all attenuated and nonsignificant.
CONCLUSIONS These prospective data suggest that self-reported periodontal disease is not an independent
predictor of subsequent cardiovascular disease in middle-aged to elderly men. (J Am Coll
Cardiol 2001;37:445–50) © 2001 by the American College of Cardiology
Results of several cross-sectional (1,2) and case-control (3,4)
studies have raised the possibility that persons with peri-
odontal disease (gingivitis or periodontitis) may have in-
creased risks of cardiovascular disease. Periodontal disease,
which is caused by Gram-negative bacteria found in the oral
flora, is common among adults in the U.S. Periodontal
pockets and loss of attachment, the anatomical sequelae of
periodontal disease, have been estimated to occur in 116
million Americans (5), while advanced destruction, as evi-
denced by pockets of $4 mm, is reported to occur in 28
million of those persons (5). Over time, the bacterial
endotoxins in the mouth may enter the systemic circulation
through gingival connective tissue and produce vascular
injury. In view of the common occurrence of the condition,
the demonstration of a role for periodontal disease in
cardiovascular disease would have important public health
implications.
There have been few prospective cohort studies of peri-
odontal disease and risk of cardiovascular disease, and the
data are inconsistent. A 14-year follow-up study of 9,760
participants in the National Health and Nutrition Epide-
miologic Follow-Up Study indicated a small, but statisti-
cally significant, 25% increased risk of coronary heart disease
(CHD) in persons with periodontal disease at baseline,
compared to those with minimal disease, based on a
periodontal score developed from a standard dental exami-
nation at baseline (6). Similarly, data from the Longitudinal
Study of Aging suggested that persons with periodontal
disease, based on an assessment of bone loss and probing
pocket depth, had a 50% increased risk of CHD, compared
to those without periodontal disease, during an 18-year
follow-up period (7). However, a study of 44,119 male
health professionals indicated no overall association between
self-reported periodontal disease and CHD, although
among those with preexisting periodontal disease, there was
an inverse relationship between the reported number of
teeth present and risks of subsequent CHD (8).
In this report, we examined the relationship between a
report of periodontal disease and subsequent cardiovascular
disease using prospective data from Physicians’ Health
Study I (PHS I), a randomized, double-blind, placebo-
controlled trial of aspirin and beta-carotene in the preven-
tion of cancer and cardiovascular disease among 22,071 U.S.
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male physicians. We also examined the relationship of
reported tooth loss during follow-up with the risk of
cardiovascular disease in the total population, and separately
among those who did and did not report periodontal disease
at baseline.
METHODS
Study population. A detailed description of the subjects
and methods of PHS I has been presented elsewhere (9).
Briefly, PHS I was a randomized, double-blind, placebo-
controlled trial of aspirin and beta-carotene in the preven-
tion of cancer and cardiovascular disease among 22,071 U.S.
male physicians aged 40 to 84 years at entry in 1982.
Participants were without a history of myocardial infarction,
stroke, transient cerebral ischemia or cancer (except non-
melanoma skin cancer). At baseline, study participants
completed mailed questionnaires providing information on
previous diagnoses of a range of diseases. Participants were
asked “Do you have a personal history of any of the
following?,” with response options including periodontal
disease. Baseline information was also collected on potential
confounding variables including age, history of diabetes
mellitus, current blood pressure level, history of high cho-
lesterol level, height, weight, alcohol use, cigarette smoking,
diuretic use, physical activity, multivitamin use and parental
history of myocardial infarction. Subsequent annual ques-
tionnaires asked about adherence to treatments and the
occurrence of study outcomes, including the number of
teeth lost, since the previous questionnaire. Participants
were asked “Since you filled out the last questionnaire
(about 12 months ago), have you been newly diagnosed as
having any of the following conditions?”, with response
options including periodontal disease and teeth loss in past
year (If yes, how many).
Ascertainment and definition of end points. Following
the report of a cardiovascular event, written consent for
review of medical records was obtained and information was
requested from hospitals and treating physicians. Reports of
cardiovascular disease were considered refuted or confirmed
only after the examination of all available information by an
end points committee blinded to participants’ periodontal
disease status. Diagnoses of nonfatal myocardial infarction
were confirmed with the use of World Health Organization
criteria (10). Nonfatal stroke was defined as a typical
neurologic deficit, either sudden or rapid in onset, that
lasted .24 h and was attributed to a cerebrovascular event.
Death due to a cardiovascular cause was confirmed by
convincing evidence of a cardiovascular mechanism from all
available sources, including death certificates, hospital
records, and—for deaths outside the hospital—observers’
impressions. Only confirmed end points were included in
this analysis.
The present report includes data as of October 1995. By
this date, participants had been followed up for an average
of 12.3 years, morbidity follow-up was 99.7% complete and
mortality follow-up was 100% complete. Records were
available for review for 94.8% of all deaths. The available
data provided power of over 0.9 to detect a clinically
important 50% increased risk of each end point (nonfatal
myocardial infarction, nonfatal stroke, cardiovascular death).
Data analysis. Rates of cardiovascular disease were calcu-
lated by dividing the number of cardiovascular events by
person-time of follow-up in the periodontal disease and no
periodontal disease groups. Cox proportional hazards re-
gression models (11) were used to assess the independent
contribution of a history of periodontal disease to the risk of
cardiovascular disease. Separate analyses were conducted for
the end points of nonfatal myocardial infarction, nonfatal
stroke and cardiovascular death. For nonfatal myocardial
infarction and nonfatal stroke, only the first confirmed event
in each category was counted. We also examined the end
point of all important cardiovascular events, a combined end
point of first occurrence of nonfatal myocardial infarction or
nonfatal stroke or cardiovascular death.
In initial regression analyses, relative risk (RR) estimates
were obtained by controlling for the effects of age and
aspirin and beta-carotene treatment assignment. To control
for the effects of multiple potential confounders, multivar-
iate models were also fit that included indicator terms for
history of diabetes (yes/no), history of hypertension (systolic
blood pressure of $160 mm Hg, diastolic blood pressure of
$95 mm Hg, or history of treatment for high blood
pressure) (yes/no), body mass index (continuous), cigarette
smoking (never, past, current [,20/day, $20/day]), alcohol
use (four categories), physical activity (reported vigorous
exercise once/week or more) (yes/no), history of angina
pectoris (yes/no) and parental history of myocardial infarc-
tion (yes/no). Interaction terms were used to examine
possible modification of the association of periodontal
disease and cardiovascular disease by baseline category of
age (,60 years, $60 years), smoking (current, not current),
alcohol (daily, less than daily), diabetes (yes/no), hyperten-
sion (yes/no), obesity (body mass index $27.8 kg/m2)
(yes/no) and aspirin assignment (active, placebo).
We also examined the association of cardiovascular dis-
ease with tooth loss reported during follow-up by modeling
tooth loss as a time-varying covariate in separate propor-
tional hazard models. Models were fit for the total popula-
tion, and for those who did and did not report periodontal
disease at baseline. For each RR, we calculated the two-
sided p value and 95% confidence interval (12).
Abbreviations and Acronyms
CHD 5 coronary heart disease
PHS I 5 Physicians’ Health Study I
RR 5 relative risk
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RESULTS
At baseline, 2,653 (12.0%) men reported a history of
periodontal disease. These men were older and, after ad-
justing for age, reported more cigarette smoking, daily
alcohol use, history of angina pectoris and diabetes, but less
physical activity, than men who did not report periodontal
disease at baseline (Table 1). Similar differences in baseline
characteristics were noted when we compared men who did
and did not report tooth loss during follow-up (data not
shown).
During an average of 12.3 years of follow-up, there were
797 nonfatal myocardial infarctions, 631 nonfatal strokes
and 614 cardiovascular deaths. In analyses adjusting for age
and treatment assignment, men who reported periodontal
disease at baseline, compared to those who did not, had
slightly elevated, but statistically nonsignificant, increased
risks of nonfatal myocardial infarction, nonfatal stroke and
cardiovascular death (Table 2). For the combined end point
of all important cardiovascular events, there was a statisti-
cally nonsignificant 13% increased risk for men who re-
ported periodontal disease at baseline. After further adjust-
ment for cigarette smoking and other possible
cardiovascular risk factors, all RRs were attenuated and near
the null value of 1.0. Tests of interaction with baseline
variables indicated no important modification of the peri-
odontal disease-cardiovascular disease association by these
variables.
A total of 6,922 participants reported losing one or more
teeth during the follow-up period. The results of multivar-
iate analyses indicated that tooth loss during follow-up was
not associated with risks of nonfatal myocardial infarction or
nonfatal stroke (Table 3). However, against the a priori
hypothesis, there was a statistically significant 39% de-
creased risk of cardiovascular death for those who reported
tooth loss. Thus, the combined end point of all important
cardiovascular events indicated an 8% lower risk for those
with tooth loss that, nevertheless, was not statistically
significant. The results were not materially different when
analyses were conducted separately among those who did
and did not report periodontal disease at baseline (Table 4).
DISCUSSION
In these prospective data from a large cohort of U.S.
physicians, men who reported a history of periodontal
disease at baseline, compared to those who reported no
periodontal disease, had small (10% to 20%), and statisti-
cally nonsignificant, increased risks of nonfatal myocardial
infarction, nonfatal stroke and cardiovascular death after
adjustment for age and treatment assignment. However,
Table 1. Characteristics of Study Participants by Self-reported
Periodontal Disease at Baseline in the Physicians’ Health
Study I
Characteristics
Periodontal Disease
at Baseline
Yes
(n 5 2,653)
No
(n 5 19,384)
Mean age, yr 55.1 53.0
40–49 31.3 42.4
50–59 37.8 33.2
60–69 22.4 18.0
701 8.5 6.4
Medical history
Reported hypertension, %* 13.9 13.9
Reported diabetes mellitus, % 3.6 2.2
Mean body mass index, kg/m2 25.0 24.9
History of angina pectoris, % 1.9 1.2
Parental history of MI, %† 13.7 13.0
Cigarette smoking
Never, % 34.4 51.7
Past only, % 45.5 38.6
Current
,20/d, % 6.0 3.6
$20/d, % 14.1 6.2
Alcohol use
Daily, % 28.9 24.3
Weekly, % 48.7 49.2
Physical activity, %‡ 66.9 73.0
*Hypertension is defined as reported systolic blood pressure of $160 mm Hg,
diastolic blood pressure of $95 mm Hg or history of treatment for high blood
pressure. †Myocardial infarction (MI) in either parent before age 60 years. ‡Reported
vigorous exercise at least once per week.
Table 2. Self-reported Periodontal Disease at Baseline and Relative Risk of Nonfatal Myocardial
Infarction, Nonfatal Stroke, Cardiovascular Death and All Important Cardiovascular Events in
the Physicians’ Health Study I
End Point
Periodontal Disease at Baseline
Adjusted for
Age and
Treatment
RR (95% CI)
Multivariate*
RR (95% CI)
Yes
(n 5 2,653)
No
(n 5 19,384)
N % N %
Nonfatal MI 115 4.3 682 3.5 1.12 (0.92–1.36) 1.01 (0.82–1.24)
Nonfatal stroke 94 3.5 537 2.8 1.10 (0.88–1.37) 1.01 (0.81–1.27)
CV death 100 3.8 514 2.7 1.20 (0.97–1.49) 1.00 (0.79–1.26)
All important CV events 275 10.4 1,555 8.0 1.13 (0.99–1.28) 1.01 (0.88–1.15)
*Adjusted for age (years), aspirin and beta-carotene treatment assignment, cigarette smoking, alcohol use, history of hypertension
(systolic blood pressure of $160 mm Hg, diastolic blood pressure of $95 mm Hg or history of treatment for high blood
pressure), body mass index, reported history of diabetes, physical activity (reported vigorous exercise once per week or more),
parental history of myocardial infarction and history of angina.
CI 5 confidence interval; CV 5 cardiovascular; MI 5 myocardial infarction; RR 5 relative risk.
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with further adjustment for cigarette smoking and other
possible cardiovascular risk factors, estimates were reduced
to the null value of 1.0. Reported tooth loss during
follow-up was not associated with risks of nonfatal myocar-
dial infarction or nonfatal stroke, but there was an unex-
pected and statistically significant 39% reduced risk of
cardiovascular death for those who reported tooth loss, an
apparent inverse association that goes against the a priori
hypothesis. Thus, these results do not support the hypoth-
esis that periodontal disease is an independent predictor of
cardiovascular disease.
Previous studies. There have been few previous prospec-
tive studies of periodontal disease and CHD, and the data
are inconsistent. A study of 9,760 adult participants in the
National Health and Nutrition Epidemiologic Follow-up
Study indicated a small, but statistically significant, 25%
increased risk of CHD in persons with periodontal disease
at baseline, compared to those with minimal periodontal
disease, after a median follow-up of 14 years (6). A similar
size increase in risk of CHD was also reported for persons
with complete tooth loss at baseline in that study. However,
information on cigarette smoking, a potentially important
confounder of these associations, was available only for a
subsample of the study population. A second prospective
study, based on combined data for 1,147 participants in the
Normative Aging Study and the Dental Longitudinal
Study, also indicated an association of periodontal disease
and CHD. Analyses conducted after an average of 18 years
Table 3. Self-reported Tooth Loss During Follow-up and Relative Risk of Nonfatal Myocardial
Infarction, Nonfatal Stroke, Cardiovascular Death and All Important Cardiovascular Events in
the Physicians’ Health Study I
End Point
Tooth Loss During Follow-up
Adjusted for
Age and
Treatment
RR (95% CI)
Multivariate*
RR (95% CI)
Yes
(n 5 6,922)
No
(n 5 15,115)
N % N %
Nonfatal MI 326 4.7 471 3.1 1.12 (0.97–1.30) 1.01 (0.87–1.17)
Nonfatal stroke 289 4.2 342 2.3 1.14 (0.97–1.34) 1.07 (0.91–1.27)
CV death 209 3.0 405 2.7 0.63 (0.53–0.75) 0.61 (0.51–0.73)
All important CV events 744 10.8 1,086 7.2 0.98 (0.89–1.08) 0.92 (0.83–1.01)
*Adjusted for age (years), aspirin and beta-carotene treatment assignment, cigarette smoking, alcohol use, history of hypertension
(systolic blood pressure of $160 mm Hg, diastolic blood pressure of $95 mm Hg or history of treatment for high blood
pressure), body mass index, reported diabetes at baseline, physical activity (reported vigorous exercise once per week or more),
parental history of myocardial infarction and history of angina.
CI 5 confidence interval; CV 5 cardiovascular; MI 5 myocardial infarction; RR 5 relative risk.
Table 4. Self-reported Tooth Loss During Follow-up and Relative Risk of Nonfatal Myocardial
Infarction, Nonfatal Stroke, Cardiovascular Death and All Important Cardiovascular Events
According to Self-reported Periodontal Disease at Baseline in the Physicians’ Health Study I
Periodontal Disease at Baseline
End Point
Tooth Loss During Follow-up
Adjusted for
Age and
Treatment
RR (95% CI)
Multivariate*
RR (95% CI)
Yes
(n 5 1,468)
No
(n 5 1,185)
N % N %
Nonfatal MI 76 5.2 39 3.3 1.45 (0.98–2.14) 1.21 (0.80–1.83)
Nonfatal stroke 64 4.4 30 2.5 1.23 (0.79–1.89) 1.20 (0.76–1.89)
CV death 51 3.5 49 4.1 0.58 (0.39–0.87) 0.64 (0.41–0.99)
All important CV events 172 11.7 103 8.7 1.06 (0.83–1.35) 1.01 (0.77–1.31)
No Periodontal Disease at Baseline
End Point
Tooth Loss During Follow-up
Adjusted for
Age and
Treatment
RR (95% CI)
Multivariate*
RR (95% CI)
Yes
(n 5 5,454)
No
(n 5 13,930)
N % N %
Nonfatal MI 250 4.6 432 3.1 1.06 (0.90–1.24) 0.97 (0.82–1.15)
Nonfatal stroke 225 4.1 312 2.2 1.12 (0.93–1.33) 1.05 (0.88–1.27)
CV death 158 2.9 356 2.6 0.61 (0.51–0.76) 0.60 (0.49–0.73)
All important CV events 572 10.5 983 7.1 0.95 (0.85–1.06) 0.90 (0.80–1.00)
*Adjusted for age (years), aspirin and beta-carotene treatment assignment, cigarette smoking, alcohol use, history of hypertension
(systolic blood pressure of $160 mm Hg, diastolic blood pressure of $95 mm Hg or history of treatment for high blood
pressure), body mass index, reported diabetes at baseline, physical activity (reported vigorous exercise once per week or more),
parental history of myocardial infarction and history of angina.
CI 5 confidence interval; CV 5 cardiovascular; MI 5 myocardial infarction; RR 5 relative risk.
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of follow-up showed that individuals with high alveolar
bone loss at baseline (defined as .20% whole mouth bone
loss) had a statistically significant 50% increased risk of
developing heart disease after controlling for age, body mass
index, systolic blood pressure, cholesterol level and diabetes
(7). There was also an approximate twofold increase in risk
of fatal CHD (controlling for age, smoking, systolic blood
pressure, diabetes) and a threefold increase in risk of stroke
(controlling for age, smoking, diastolic blood pressure,
diabetes, family history of heart disease, education) associ-
ated with high alveolar bone loss at baseline. However, the
lack of detailed information on cigarette smoking (current
smokers were defined as men who smoked one or more
cigarettes daily) raises the possibility that residual confound-
ing by smoking (and perhaps other risk factors) may have
contributed to the findings of this study. Finally, no asso-
ciation was observed between self-reported periodontal
disease and subsequent CHD in a six-year follow-up study
of 44,119 male health professionals (8). Among men who
reported pre-existing periodontal disease, however, men
with #10 teeth at the beginning of follow-up, compared
with men with $25 teeth, had an almost 70% increased risk
of CHD.
Comparison between this and other studies. Our find-
ings in a population of male physicians appear to agree with
the results from the male health professionals study in
indicating no association between self-reported periodontal
disease and risk of cardiovascular disease. Our findings
regarding tooth loss, however, appear to conflict with those
from the male health professionals. This apparent discrep-
ancy may be related to the way in which tooth loss was
defined in the two populations. In the male health profes-
sionals study, tooth loss was defined as the reported number
of teeth at baseline, and the authors suggest that tooth loss
among participants who also reported periodontal disease
may be a marker of severe periodontal disease. In PHS I, we
did not ask about number of teeth at baseline, but instead
requested study participants to report new tooth loss (within
the past year) on each of the annual follow-up question-
naires. Thus, a report of recent tooth loss in our study may
have been a marker of comparatively good health; that is, a
participant willing to undergo elective procedures. The
additional observation that the reduction in risk of death
was greater in older ($60 years) than in younger (,60
years) men who reported tooth loss (RRs 0.55 vs 0.73,
respectively) appears consistent with this possibility. Alter-
natively, our unexpected finding of a reduced risk of
cardiovascular death for those who reported tooth loss may
simply have been a chance observation.
Possible study limitations. Several limitations of the study
need to be considered. Because we did not conduct oral
examinations of study participants, but instead relied on
participant reports of periodontal disease (medical records
to confirm the reports were not requested), some reports of
periodontal disease may have been in error, and some true
cases of periodontal disease may have been missed. The
reported prevalence of periodontal disease at baseline in
PHS I (12%) appears lower than that reported for other
populations and may reflect some degree of underascertain-
ment of disease. For example, the U.S. Public Health
Service reported that 5% to 20% of the population suffer
from severe generalized periodontal disease, and men are
more likely to be affected than are women (5).
Misclassification of participants’ periodontal disease sta-
tus that was random with respect to subsequent cardiovas-
cular disease would have biased the estimates toward the
null, and may have contributed to our null findings. It seems
unlikely, however, that the magnitude of random misclas-
sification in our study would have been sufficient to cause us
to miss a twofold to threefold increased risk of cardiovas-
cular disease reported in several earlier studies. Although we
did not validate the self-reports, a previous validation study
conducted among dentists indicated reasonable predictive
values for reported periodontal disease (predictive value
positive, 0.76; predictive value negative, 0.74), with an
expected attenuation of estimates of approximately 30%
(13). Among nondentists in that study, self-reports of
periodontal disease showed validity by confirmation of
known associations with age and cigarette smoking. Al-
though the degree of misclassification of self-reported
periodontal disease in PHS I is likely to be somewhat higher
than that observed in dentists, we similarly noted associa-
tions of reported periodontal disease with age and cigarette
smoking, thus providing support for the validity of this
measure in our study of male physicians. Misclassification of
cardiovascular disease was unlikely in our study because of
the use of strict criteria to define cardiovascular end points.
Potential bias due to unavailability for follow-up was min-
imized by the high follow-up rate in PHS I. As of October
1995, 99.7% were still providing information on morbidity,
follow-up for mortality was 100% complete and records
were available for review for 94.8% of all deaths.
Although the idea that oral disease might have an effect
on certain aspects of general health is not new, it has
recently received renewed interest in the dental scientific
community. The most plausible theory for an association
remains the suggestion that infections and infectious agents
found in the oral cavity could cause chronic inflammation,
changes in platelet aggregation and other events associated
with cardiovascular disease (14). The results from a popu-
lation of physicians presented herein, however, suggest that
self-reported periodontal disease may not be an independent
risk factor for cardiovascular disease.
Reprint requests and correspondence: Dr. William G. Christen,
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